BPC-157: NO system modulation, VEGF/FGF-2 upregulation, FAK-paxillin pathway, gastric juice stability GHK-Cu: Cu2+-dependent gene regulation (~4,000 genes), TGF-beta signaling, collagen/decorin synthesis, SOD/catalase induction BPC-157: No metal cofactor required activity is sequence-dependent GHK-Cu: Copper stoichiometry (1:1) is essential apo-GHK shows reduced bioactivity BPC-157 Research Areas: Gut & Tendon Studies The majority of BPC-157 research originates from a single laboratory group (Sikiric et al., University of Zagreb), which has published extensively on its effects in rodent models
Some notable safety-related conclusions from scientific materials include: A 2016 review of TB4 for dermal healing: The safety profile is excellent, and no preclinical toxicology has been found.22 A 2016 clinical trial on patients with STEMI: Our pilot study suggested that T4-optimized EPC transplantation appeared to be feasible and safe.34 A 2021 review of TB4 research: It was well tolerated and safe in healthy people and suitable for use in a clinical study.21 Though the compound itself may be generally safe for adults to use, some common side effects from TB4 injections reported by patients and doctors include: Injection site reactions (e.g., redness, mild swelling, or pain) Mild gastrointestinal symptoms Headaches and dizziness Rare but more serious side effects can include fever, blistering at the injection site, muscle aches, skin rash, vomiting, severe itching, or hives
Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis
W., Zarghami, N., Hanifehpour, Y., & Nejati-Koshki, K
